Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

1.480 USD -0.040 (-2.63%)
Official Closing Price Updated: 6:02 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Geron Corp

< Previous 1 2
...
21 22 23 24 25 26 27 28 Next >
Geron Moves Into New Trading Range Above $6.06 (GERN)
From Comtex SmarTrend® News Briefs
Shares of Geron are Moving Higher on 1.3x Above-Average Volume (GERN)
From Comtex SmarTrend® News Briefs
Geron Upward Momentum Looks to Continue (GERN)
From Comtex SmarTrend® News Briefs
UPDATE 1-Second US company gets stem cell go-ahead
* Trial to enroll patients with Stargardt's macular dystrophy 
Tags companyNews
From Reuters: Company News
FACTBOX-Embryonic stem cells: controversial yet powerful
Nov 22 (Reuters) - A Massachusetts company has received the go-ahead from the U.S. Food and Drug Administration to test a treatment based on human embryonic stem cells in people with a progressive... 
Tags companyNews
From Reuters: Company News
Advanced Cell Technology to start stem cell trial
WASHINGTON, Nov 22 (Reuters) - Massachusetts-based Advanced Cell Technology said the U.S. Food and Drug Administration approved a clinical trial of its human embryonic stem cell treatment for a... 
Tags companyNews
From Reuters: Company News
Earnings Flashback: Since Reporting Quarterly Results 15 Days Ago Geron Is Up 2.99% (GERN)
From Comtex SmarTrend® News Briefs
UPDATE 1-StemCells plans chronic spinal cord injury trial
LOS ANGELES, Nov 15 (Reuters) - StemCells Inc has filed for Swiss regulatory approval for the first clinical trial of its nerve stem cells in patients with spinal cord injuries as much as a year old,... 
Tags companyNews
From Reuters: Company News
StemCells plans chronic spinal cord injury trial
LOS ANGELES, Nov 15 (Reuters) - StemCells Inc has filed for Swiss regulatory approval for the first clinical trial of its nerve stem cells in patients with spinal cord injuries as much as a year old,... 
Tags companyNews
From Reuters: Company News
Geron Rises 4.83% on Heavy Volume: Watch For Potential Pullback (GERN)
From Comtex SmarTrend® News Briefs
Shares of Geron are Moving Higher on 1.1x Above-Average Volume (GERN)
From Comtex SmarTrend® News Briefs
Geron: The Trend Continues Higher (GERN)
From Comtex SmarTrend® News Briefs
Earnings Look Ahead: In 4 Days, Geron Releases Its Quarterly Numbers (GERN)
From Comtex SmarTrend® News Briefs
SmarTrend's Candlestick Scanner Detects Possible Bullish Harami Pattern for Geron (GERN)
From Comtex SmarTrend® News Briefs
Geron Begins Embryonic Stem Cell Treatment In Humans
Geron Corp. (Nasdaq: GERN) began the nation's first clinical trial using embryonic stem cells for the treatment of injuries in humans lifting the stock price 70 cents to close at $6.37.... 
From MarketMinute.com Stock News
Markets Mixed Over Potential Currency War
The markets traded mixed during the midday with the Dow falling 35 points to 10,974 while Nasdaq added 4 points to 2406 over growing concerns of an international currency war. 
Tags Market News
From MarketMinute.com Market Updates
Traders Ride the Bull in Geron as Call Volume Surges (GERN)
From Comtex SmarTrend® News Briefs
Geron Call Volume Up 4x as Traders Speculate On Higher Prices (GERN)
From Comtex SmarTrend® News Briefs
Getting into stem cells study will be tough-doctor
CHICAGO, Oct 11 (Reuters) - Only eight people will take part in the first known clinical trial testing the safety of embryonic stem cells in humans and each patient will go through a very stringent... 
Tags companyNews
From Reuters: Company News
Geron Corp. Initiates First Human Study Of Embryonic Stem-Cell Therapy (GERN)
From Comtex SmarTrend® News Briefs
Biotechs may see movement in late trade
ImmunoGen, Pozen may stay busy through the evening-trading session. 
Tags DJIA ALXA IMGN
From MarketWatch
Geron Reports First Patient Enrollment in Stem Cell Trial
Geron said the first patient has enrolled in its clinical trial of its stem cell-based drug being studied as a treatment for spinal cord injury. 
From FOX Business
FACTBOX-Embryonic stem cells: controversial yet powerful
Oct 11 (Reuters) - Doctors have begun testing human embryonic stem cells on a patient for the first time, Geron Corp. said on Monday. [ID:nN11175966] 
Tags companyNews
From Reuters: Company News
Volume Spike Detected in Shares of Geron as They Move Higher on 1.5x Above-Average Volume (GERN)
From Comtex SmarTrend® News Briefs
REFILE-UPDATE 1-First US patient treated in stem cell trial
WASHINGTON, Oct 11 (Reuters) - Doctors have begun treating the first patient in the United States to receive human embryonic stem cells, but details of the landmark clinical trial are being kept... 
Tags companyNews
From Reuters: Company News
SmarTrend's Candlestick Scanner Detects Possible Bearish Engulfing Pattern for Geron (GERN)
From Comtex SmarTrend® News Briefs
SmarTrend's Option Scanner Detects Unusual Activity in Geron (GERN)
From Comtex SmarTrend® News Briefs
Rally Loses Steam Despite Jobs Data
U.S. stocks pared their gains Thursday afternoon as a jobs-report fueled rally threatened to be derailed by more concerns about the health of Europe's banking system. 
From FOX Business
Geron Shares Are Up 5.32% After It Announced A Compound That Could Stop Or Reverse Aging (GERN)
From Comtex SmarTrend® News Briefs
Santarus, Geron lead drug stocks north
Santarus Inc. leads drug stocks north as shares of the biotech group zoomed skyward on news that it has obtained the exclusive U.S. license to commercialize the diabetes drug Cycloset. 
Tags $BTK $DRG Biotechnology
From MarketWatch
< Previous 1 2
...
21 22 23 24 25 26 27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback